You searched for: chronic disease
51 to 60 of 72 results
Show
results per page
Matched phrases in profile:
A role for primary care pharmacists in the management of inflammatory bowel disease? Lessons from chronic disease: A systematic review… A practice change for patients with severe chronic, clinically unexplained gastrointestinal… Introduction: Inflammatory bowel disease (IBD) is a chronic condition, yet the model of care is…
Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hos …
Matched phrases in profile:
Atorvastatin and the progression of chronic kidney disease: The LORD Trial… Oxidative Stress in Chronic Kidney Disease… To describe adults with (non-dialysis) chronic kidney disease (CKD) in 9 public renal practice…
Matched phrases in profile:
Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia… Prudence: a factorial randomised trial testing a 'mass strategy' for the primary prevention of chronic degenerative diseases… prevention of chronic non-communicable diseases. This study evaluated the effectiveness of a minimal…
Matched phrases in profile:
complications including kidney disease. Excess blood sugar as the result of diabetes can accelerate a… Dietary AGEs in the development and progression of chronic kidney disease… Identification of a novel target for the treatment of diabetic kidney disease… corroborated in a non-diabetic model of chronic kidney disease, the subtotal nephrectomised rat. Thus, our…
Matched phrases in profile:
Genetic influences on right ventricular systolic pressure (RVSP) in chronic obstructive pulmonary disease (COPD)… Genome-wide association study of protective alleles in lung cancer and chronic obstructive pulmonary disease… Infection frequently causes exacerbations of chronic obstructive pulmonary disease (COPD). Mannose…
Matched phrases in profile:
Heart attacks and kidney disease from a lack of blood flow are common causes of morbidity and have… Hepatic fibrosis is associated with small intestinal permeability in chronic liver disease due… The application of adipose-derived stem cells and stem cell secretions to the treatment of renal disease.… , a senior member of the UQ Kidney Disease Research Laboratory and manages the Princess Alexandra… hypertension, and 9% had chronic kidney disease (CKD). The BMDL value of E-Cd associated with kidney…
David graduated from the University of London with a BSc (Hons) in biochemistry (King’s College) and PhD which investigated the role of epidermal growth factor receptors in liver regeneration (Imperial College). Since then he has worked on a variety of projects including; immunoassay development ( …
Matched phrases in profile:
Chronic liver diseases such as hepatitis C and obesity-related fatty liver can be associated with… with haemochromatosis and other chronic liver diseases American Association for the Study of Liver Diseases… Identifying Protective v Pathogenic Macrophages in Chronic Liver Disease: Critical for Macrophage-Targeted Therapy… Background & Aims: Fibrosis, the primary cause of morbidity in chronic liver disease, is…
Matched phrases in profile:
Improving diverse and equitable involvement of consumers in chronic kidney disease research: Workshop report… The GOAL Trial: Comprehensive geriatric assessment for frail older people with chronic kidney… clinical trials in people with chronic kidney disease. As a Coordinating Committee member, Transplant… heterogeneity in transplantation payor mix. Services for chronic kidney disease, such as monitoring…
A/Prof Andrea Viecelli is an academic nephrologist at Princess Alexandra Hospital in Brisbane, Australia and was awarded her PhD on strategies to improve vascular access outcomes in patients on haemodialysis in 2019 through the University of Queensland. As a clinical trialist of the Australasian Kid …
As global Standardised Outcomes in Nephrology (SONG) Investigator and Project Coordinator, she has facilitated multiple national and international workshops and involved over >10,000 consumers, health professionals, and policy makers from >100 countries to establish and standardise critically import …
Matched phrases in profile:
productivity. It is also a time when animals are especially susceptible to infectious disease. This project… strategic funding (CRC for Chronic Inflammatory Disease, ARC Special Research Centre in Australia… Therapeutic potential of macrophage colony-stimulating factor (CSF1) in chronic liver disease… CSF1 Therapy for Chronic Liver Disease… weeks reactivated the disease and extended the chronic phase. These data in combination with previous…
The research interests of the Hume Laboratory centre on the biology of macrophages and osteoclasts. These are cells of haematopoietic origin that are closely related to each other but have distinctly different activities.
David Hume was a group leader at the Institute for Molecular Bioscience (1988 …
Matched phrases in profile:
Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of parkinson’s disease… Novel therapeutic strategies targeting the microbiota and gut-brain axis in Parkinson's disease… Repurposing of clinically validated kinase inhibitors to block chronic neuroinflammation and disease progression in Parkinson's disease… changes seen in Parkinson's disease (PD) and other neurological disorders. Clinical studies suggest that… Clinical bio-markers for early detection of Parkinson's disease… mechanisms which drive the onset and progression of neurodegenerative disorders such as Parkinson’s disease… other related chronic neurodegenerative diseases. PK2 signals through its receptors on astrocytes and…
Dr. Richard Gordon leads a multi-disciplinary, industry-partnered research program in Translational Neuroscience which integrates immunology, drug development, pharmacology, metabolomics and microbial metagenomics. His group aims to understand and therapeutically target key pathological mechanisms w …
Dr. Gordon’s research has contributed to ground-breaking advances in the field of neuroinflammation and Parkinson’s disease, including discovery of a novel signalling paradigm for prokineticin signalling during neurodegeneration, and inflammasome activation as a driver of synuclein pathology and …